suck pdf from google scholar
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text


  • DeepDyve
  • Pubget Overpricing


  • lüll
  • Appetite suppression based on selective inhibition of NPY receptors
  • Chamorro S; Della-Zuana O; Fauchere JL; Feletou M; Galizzi JP; Levens N
  • Int J Obes Relat Metab Disord 2002[Mar]; 26 (3): 281-98
  • AIM: The aim of this review is to critically assess available evidence that blockade of the actions of NPY at one of the five NPY receptor subtypes represents an attractive new drug discovery target for the development of an appetite suppressant drug. RESULTS: Blockade of the central actions of NPY using anti-NPY antibodies, antisense oligodeoxynucleotides against NPY and NPY receptor antagonists results in a decrease in food intake in energy-deprived animals. These results appear to show that endogenous NPY plays a role in the control of appetite. The fact that NPY receptors exist as at least five different subtypes raises the possibility that the actions of endogenous NPY on food intake can be adequately dissociated from other effects of the peptide. Current drug discovery has produced a number of highly selective NPY receptor antagonists which have been used to establish the NPY Y(1) receptor subtype as the most critical in regulating short-term food intake. However, additional studies are now needed to more clearly define the relative contribution of NPY acting through the NPY Y2 and NPY Y5 receptors in the complex sequence of physiological and behavioral events that underlie the long-term control of appetite. CONCLUSIONS: Blockade of the NPY receptor may produce appetite-suppressing drugs. However, it is too early to state with certainty whether a single subtype selective drug used alone or a combination of NPY receptor selective antagonists used in combination will be necessary to adequately influence appetite regulation.
  • |*Appetite Depressants[MESH]
  • |Animals[MESH]
  • |Antibodies/pharmacology[MESH]
  • |Brain/drug effects/metabolism[MESH]
  • |Drug Design[MESH]
  • |Eating/drug effects[MESH]
  • |Energy Metabolism[MESH]
  • |Humans[MESH]
  • |Mice[MESH]
  • |Mice, Knockout[MESH]
  • |Naphthalenes/pharmacology[MESH]
  • |Neuropeptide Y/antagonists & inhibitors/genetics/immunology/pharmacology[MESH]
  • |Oligodeoxyribonucleotides, Antisense/pharmacology[MESH]
  • |Pyrimidines/pharmacology[MESH]
  • |Receptors, Neuropeptide Y/*antagonists & inhibitors/deficiency/metabolism[MESH]





  • *{{pmid11896483}}
    *<b>[http://www.kidney.de/mlpefetch.php?search=11896483 Appetite suppression based on selective inhibition of NPY receptors ]</b> Int J Obes Relat Metab Disord 2002; 26(3) ; 281-98 Chamorro S; Della-Zuana O; Fauchere JL; Feletou M; Galizzi JP; Levens N

        *11896483*

    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    Int J Obes Relat Metab Disord

    281 3.26 2002